本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2003/5/281 分钟阅读
Determination That Periactin Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) has determined that Periactin (cyproheptadine hydrochloride (HCl)) 4-milligram (mg) tablets were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for cyproheptadine HCl 4-mg tablets.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →